ClinicalTrials.gg
Drug

Xanomeline clinical trials

Also written BMS-986519.

studies test it
42
open now
28
in phase 3
30
first study started
2018

Counted the way a researcher would: Xanomeline with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses xanomeline is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the xanomeline studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
26 Sept 2024 · COBENFY · NDA 216158 (FDA, Drugs@FDA; in a combination)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

KarX-EC
10
Xanomeline Enteric-coated
4
Xanomeline Enteric Capsule
3
Xanomeline
1

Development codes

BMS-986519
9

In one entry with another drug

Given together, or one or the other

KarXT
33
Xanomeline/Trospium Chloride
10
Xanomeline and Trospium Chloride Capsules
9
Xanomeline and trospium chloride
3
Xanomeline/Trospium
2
Xanomeline/Trospium Chloride Capsule
2

Studies by the year they started

41 studies that test it; most in 2025 (16); 1 more planned to start later

Studies that test xanomeline, by start year
YearStudies
20181
20201
20214
20223
20233
20243
202516
202610

By phase

A phase 1/2 study counts in both.

Phase 1
6
Phase 2
2
Phase 3
30
Phase 4
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 38 · Other 4

Bristol-Myers Squibb (18) · Karuna Therapeutics, Inc., a Bristol Myers Squibb company (15) · Karuna Therapeutics (5) · Vanguard Research Group (1) · Collaborative Neuroscience Research, LLC (1) · New York State Psychiatric Institute (1) · European Group for Research In Schizophrenia (1)

Often tested with

Tested in the same studies.

Trospium (33) · Trospium chloride (10) · Omeprazole (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 11, 6 in phase 3

Studies that test xanomeline, phase 3 first.

Studies

Open first, then newest update. How each study uses xanomeline is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 42

See all 42 studies that test xanomeline →

Given beside what is tested · 3 — xanomeline is usual care or a partner of the new treatment

Codes

What other systems call xanomeline · ClinicalTrials.gg INT003639

  • MeSH (NLM) C075257xanomelineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 9ORI6L73CJXANOMELINEConfirmed FDA, NLM, Wikidata
  • Wikidata Q8042940xanomelineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152926XanomelineOne source FDA
  • DrugBank DB15357One source Wikidata

Also registered as xanomeline tartrate (UNII B80W7AUT8R).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.